Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON33042Active, not recruiting
Randomised, double-blind trial in pain comparing Ropivacaine alone with Ropivacaine plus epinephrine (2 arms). Primary endpoints: Mean unbound peak plasma concentration of ropivacaine, Mean bound peak plasma concentration of ropivacaine and 6 more. Started Oct 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON33042.